Business Context and Reporting Period
Company: Champions Oncology, Inc. (CSBR)
Filing Type: Form 8-K (Current Report)
Report Date: December 15, 2025
Reporting Period: Second Quarter ended October 31, 2025
Context: The filing serves to announce the issuance of a press release containing unaudited financial results for the quarter ended October 31, 2025. The detailed financial data is contained in Exhibit 99.1 (Press Release) and is not embedded directly in the text of this 8-K form.
Key Financial Metrics
The provided text of the Form 8-K does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the filing text itself.
Material Changes
No material changes or comparative financial data versus prior periods are disclosed within the text of this filing. The document solely references the release of the Q2 2025 results.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release regarding Q2 2025 results but does not include specific commentary, guidance, or outlook statements in the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Legal Disclaimer: The information under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated December 15, 2025) for actual revenue, net loss, and cash position figures.
- Verify the unaudited nature of the financial results for the quarter ended October 31, 2025.
- Check for any forward-looking statements or updated clinical trial milestones in the attached press release.
- Confirm the company's status as a non-emerging growth company based on the checkmarks in the filing.